TGA orders ad retraction
February 7, 2014
The Therapeutic Goods
Administration (TGA) has ordered
Lifelixer Pty Ltd to withdraw
advertisements and publish a
retraction on its websites.
The company failed to fully
comply with the Complaints
Resolution Panel’s determination in
October 2012, so the TGA delegate
of the Secretary of the Department
of Health reviewed the two internet
advertisements.
The ads for the product, described
in a copy of the advertisement
included in the decision as a “natural
mind and body regeneration tonic”,
were found by the Delegate likely to,
among other things, lead consumers
to inappropriately treat potentially
serious diseases.
The Delegate ordered Lifelixer Pty
Ltd to withdraw representations
that the product was for any
therapeutic use that offered
benefits in relation to a list of
over 50 items, including lifespan,
kidneys, liver, mental clarity and
bipolar conditions.
Lifelixer was also ordered to
display a retraction on its website
for 90 days, which read in part
that the company had provided
no evidence to support the claims
made, and that the Panel found the
claims “unlawful, misleading and
unverified.”
Lifelixer has 10 working days to
provide evidence of compliance
and a written response that it will
continue to abide by the TGA order.
A response from the Advertiser
had not yet been received by the
TGA, however the advertising
subject of the complaint had been
withdrawn, a TGA spokesperson
said.
Lifelixer representative Karen
Phillips said the company would be
complying with TGA instructions
to remove the site and had been
trying for several weeks, but had
had issues with its web host.
The company was disappointed
with the course of the process, she
said, and felt the TGA should insist
on complainants being identified.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Feb 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Feb 14
